课题基金 / 基金详情

Next Generation Antithrombotics: Safer Inhibitors for Thrombosis that Targets Procoagulant Polyanions

Next Generation Antithrombotics: Safer Inhibitors for Thrombosis that Targets Procoagulant Polyanions
下一代抗血栓药:针对促凝血聚阴离子的更安全的血栓形成抑制剂
批准号:
357533
负责人:
Kizhakkedathu Jayachandran N
金额:
$66.88万
依托单位国家:
加拿大
项目类别:
Operating Grants
财政年份:
2016
资助国家:
加拿大
项目状态:
已结题
起止时间:
2016-10-01 至 2021-10-01

项目摘要

项目成果

Kizhakkedathu Jayachandran N的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Thrombosis- clotting of the blood in blood vessels- is the leading cause of death in Canada and in the Developed society. Blood clot formation in arteries (blood supply vessels) is a major cause of majority of heart attacks and stroke. Blood clot in veins
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Localized immuno-cloaking organ engineering approach to prevent transplant rejection without immunosuppressants
  • 批准号:
    468759
  • 项目类别:
    Operating Grants
  • 资助金额:
    $58.52万
  • 财政年份:
    2022
  • 负责人:
    Kizhakkedathu Jayachandran N
  • 依托单位:
Canada Research Chair - Tier 1
  • 批准号:
    459641
  • 项目类别:
  • 资助金额:
    $101.99万
  • 财政年份:
    2021
  • 负责人:
    Kizhakkedathu Jayachandran N
  • 依托单位:
Novel endothelial engineering and localized immunosuppression approaches for the protection of organ transplants
  • 批准号:
    418915
  • 项目类别:
    Operating Grants
  • 资助金额:
    $66.88万
  • 财政年份:
    2020
  • 负责人:
    Kizhakkedathu Jayachandran N
  • 依托单位:
Novel Infection Resistant Coating in an Era of Drug Resistant Bacteria for the Treatment and Prevention of Medical Device Infection
  • 批准号:
    433420
  • 项目类别:
    Operating Grants
  • 资助金额:
    $37.9万
  • 财政年份:
    2020
  • 负责人:
    Kizhakkedathu Jayachandran N
  • 依托单位:
海外基金